Evaluation of enantioselective binding of fluoxetine to human serum albumin by ultrafiltration and CE - experimental design and quality considerations

Electrophoresis

Volumn 31, Issue 19, 2010, Pages 3268-3280

  Asensi Bernardi, Lucía ^a   Martin Biosca, Yolanda ^a   Villanueva Camañas, Rosa María ^a   Medina Hernández, María José ^a   Vives, Salvador Sagrado ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

EKC; Enantioselective binding; Fluoxetine; HSA; Quality protocol

Indexed keywords

BINDING SITES; ENANTIOMERS; PROTEINS; QUALITY CONTROL; ULTRAFILTRATION; UNCERTAINTY ANALYSIS;

AFFINITY CONSTANTS; CHIRAL ANALYSIS; EKC; ENANTIOSELECTIVE BINDING; FLUOXETINE; HSA; HUMAN SERUM ALBUMINS; MIXTURE ANALYSIS; PROTEIN-BINDING; QUALITY PROTOCOLS;

ENANTIOSELECTIVITY;

FLUOXETINE; SERUM ALBUMIN;

ALGORITHM; ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; NONLINEAR SYSTEM; PROTEIN BINDING; REPRODUCIBILITY; STEREOISOMERISM; ULTRAFILTRATION;

ALGORITHMS; ELECTROPHORESIS, CAPILLARY; FLUOXETINE; HUMANS; NONLINEAR DYNAMICS; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; STEREOISOMERISM; ULTRAFILTRATION;

EID: 79955090278     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.201000250     Document Type: Article

References (21)

1. Brocks, D. R., Biopharm. Drug Dispos. 2006, 27, 387-406.
2. Ascoli, G. A., Domenici, E., Bertucci, C., Chirality 2006, 18, 667-679.
3. Kwong, T. C., Clin. Chim. Acta 1985, 151, 193-216.
4. Kurz, H., Methodological Problems in Drug Binding Studies, in: Drug Protein Binding, Praeger Publishers, New York 1986, 70-92.
5. Chuang, V. T. G., Otagiri, M., Chirality 2006, 18, 159-166.
6. Martínez-Gómez, M. A., Villanueva-Camañas, R. M., Sagrado, S., Medina-Hernández, M. J., Electrophoresis 2007, 28, 2635-2643.
7. Robertson, D. W., Krushinski, J. H., Fuller, R. W., Leander, J. D., J. Med. Chem. 1988, 31, 1412-1417.
8. Katrahalli, U., Jaldappagari, S., Kalanur, S. S., Spectrochim. Acta A 2010, 75, 314-319.
9. Fielding, L., Rutherford, S., Fletcher, D., Magn. Reson. Chem. 2005, 43, 463-470.
10. Jannuzzi, G., Gatti, G., Magni, P., Spina, E. et al., Ther. Drug Monit. 2002, 24, 616-627.
11. Soltés, L., Mach, M., J. Chromatogr. B 2002, 768, 113-119.
12. Busch, M. H. A., Carels, L. B., Boelens, H. F. M., Kraak, J. C., Poppe, H., J. Chromatogr. A 1997, 777, 311-328.
13. Barri, T., Trtic-Petrovic, T., Karlsson, M., Jönsson, J. A., J. Pharm. Biomed. Anal. 2008, 48, 49-56.
14. Mehvar, R., Am. J. Pharm. Educ. 2005, 69, 1-8.
15. Kragh-Hansen, U., Mol. Pharmacol. 1988, 34, 160-171.
16. Massart, D. L., Vandeginste, B. G. M., Buydens, L. M. C., De Jong, S. et al., Handbook of Chemometrics and Qualimetrics, Part A, Elsevier, Amsterdam 1997.
17. Martínez-Gómez, M. A., Sagrado, S., Villanueva-Camañas, R. M., Medina-Hernández, M. J., Electrophoresis 2006, 27, 3410-3419.
18. Koyama, H., Sugioka, N., Uno, A., Mori, S., Nakajima, K., Biopharm. Drug Dispos. 1997, 18, 791-801.
19. Chen, J., Hage, D. S., Anal. Chem. 2006, 78, 2672-2683.
20. Mcdonnell, P. A., Caldwell, G. W., Masucci, J. A., Electrophoresis 1998, 19, 448-454.
21. Bisetty, K., Gumede, M. J., Escuder-Gilabert, L., Sagrado, S., J. AOAC Int. 2009 92 1821-1832.